File(s) under permanent embargo
Is home-based palliative care cost-effective? An economic evaluation of the Palliative Care Extended Packages at Home (PEACH) pilot
journal contribution
posted on 2013-12-01, 00:00 authored by Nikki McCaffreyNikki McCaffrey, M Agar, J Harlum, J Karnon, D Currow, S EckermannOBJECTIVE: The aim of this study was to evaluate the cost-effectiveness of a home-based palliative care model relative to usual care in expediting discharge or enabling patients to remain at home. DESIGN: Economic evaluation of a pilot randomised controlled trial with 28 days follow-up. METHODS: Mean costs and effectiveness were calculated for the Palliative Care Extended Packages at Home (PEACH) and usual care arms including: days at home; place of death; PEACH intervention costs; specialist palliative care service use; acute hospital and palliative care unit inpatient stays; and outpatient visits. RESULTS: PEACH mean intervention costs per patient ($3489) were largely offset by lower mean inpatient care costs ($2450) and in this arm, participants were at home for one additional day on average. Consequently, PEACH is cost-effective relative to usual care when the threshold value for one extra day at home exceeds $1068, or $2547 if only within-study days of hospital admission are costed. All estimates are high uncertainty. CONCLUSIONS: The results of this small pilot study point to the potential of PEACH as a cost-effective end-of-life care model relative to usual care. Findings support the feasibility of conducting a definitive, fully powered study with longer follow-up and comprehensive economic evaluation.
History
Journal
BMJ supportive and palliarive careVolume
3Issue
4Pagination
431 - 435Publisher
BMJ GroupLocation
London, Eng.Publisher DOI
eISSN
2045-4368Language
engPublication classification
C1.1 Refereed article in a scholarly journal; C Journal articleCopyright notice
[2013, BMJ Group]Usage metrics
Categories
No categories selectedKeywords
CancerHome careService evaluationSupportive careTerminal careAgedAged, 80 and overCase-Control StudiesChronic DiseaseCost-Benefit AnalysisEnglandFemaleHome Care ServicesHumansMaleMiddle AgedPalliative CarePatient AdmissionPilot ProjectsState MedicineScience & TechnologyLife Sciences & BiomedicineHealth Care Sciences & ServicesDEATH
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC